SEC Comment Letter for VOLITIONRX LTD (VNRX) (CIK 0000093314) (VNRX) — Sep 18, 2018
VOLITIONRX LTD (VNRX) (CIK 0000093314)
Date: Sept. 18, 2018 · CIK: 0000093314 · Accession: 0000000000-18-029108
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227248
Letter
September 17, 2018 Cameron Reynolds President and Chief Executive Officer VolitionRx Limited 1 Scotts Road #24-05 Shaw Centre Singapore 228208 Re:VolitionRx Limited Registration Statement on Form S-3 Filed September 10, 2018 File No. 333-227248 Dear Mr. Reynolds: We have limited our review of your registration statement to those issues we have addressed in our comment. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to the comment, we may have additional comments. Registration Statement on Form S-3 Incorporation of Certain Information by Reference, page 14 1.Please revise this section to incorporate by reference the Form 8-K you filed on March 12, 2018. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
FirstName LastNameCameron Reynolds Comapany NameVolitionRx Limited September 17, 2018 Page 2 FirstName LastName Cameron Reynolds VolitionRx Limited September 17, 2018 Page 2 time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Dorrie Yale at 202-551-8776 or Erin Jaskot at 202-551-3442 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Marc G. Alcser
Show Raw Text
September 17, 2018
Cameron Reynolds
President and Chief Executive Officer
VolitionRx Limited
1 Scotts Road
#24-05 Shaw Centre
Singapore 228208
Re:VolitionRx Limited
Registration Statement on Form S-3
Filed September 10, 2018
File No. 333-227248
Dear Mr. Reynolds:
We have limited our review of your registration statement to those issues we have
addressed in our comment. In some of our comments, we may ask you to provide us with
information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to the comment, we may have additional comments.
Registration Statement on Form S-3
Incorporation of Certain Information by Reference, page 14
1.Please revise this section to incorporate by reference the Form 8-K you filed on March 12,
2018.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
FirstName LastNameCameron Reynolds
Comapany NameVolitionRx Limited
September 17, 2018 Page 2
FirstName LastName
Cameron Reynolds
VolitionRx Limited
September 17, 2018
Page 2
time for us to review any amendment prior to the requested effective date of the registration
statement.
Please contact Dorrie Yale at 202-551-8776 or Erin Jaskot at 202-551-3442 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Marc G. Alcser